results: PCSK4 is predominantly expressed in male germ cells and located on the plasma membrane overlying the acrosome of sperm.
Introduction
Proprotein convertase subtilisin/kexin type 4 (PCSK4), also known as proprotein convertase 4 (PC4), belongs to a nine-member family of calcium-dependent serine endoproteinases involved in the proteolytic activation of secretory precursor proteins to their bioactive forms (Van de Ven et al., 1993; Seidah et al., 1994; Steiner, 1998; Seidah and Chretien, 1999; Seidah and Prat, 2002) . Its transcripts and protein are primarily found in testicular germ cells and sperm (Nakayama et al., 1992; Seidah et al., 1992; Torii et al., 1993; Gyamera-Acheampong et al., 2006) , but its transcripts are also detectable in ovary (Tadros et al., 2001) , placenta (Qiu et al., 2005) and oocytes (St. Germain et al., 2005) . Consistent with its distribution in reproductive tissues, inactivation of its gene in mice causes male infertility to males and subfertility to females (Mbikay et al., 1997) . The high conservation of the PCSK4 sequence and its expression pattern among tetrapods suggests that this enzyme may have played a critical role for reproductive success during evolution. Yet much remains to be elucidated about its natural substrates and their roles in reproductive physiology. In this review, we sum up current knowledge on PCSK4 biology: we briefly describe biochemical properties common to all PCSKs before expanding on particularities of PCSK4 structure, expression and enzymatic activity; we then assess the contribution of this enzyme to reproduction as learned from the phenotypic characterization of PCSK4-null mice; lastly, we discuss the possible usefulness of PCSK4 as a marker of fertility and target for nonhormonal contraception.
Methods
Relevant publications were searched in PubMed using as keywords the various names of PCSK4 and its related enzymes. In addition, we searched genetics and molecular biology online databases (NCBI, Ensembl, HapMap, Expasy) for PCSK4 protein, RNA or DNA sequences across species as well as for annotations of interest. Finally, we used online algorithms for comparative analysis of conserved potentially functional motifs in PCSK4 DNA and protein sequences. These algorithms are specified in the text.
PCSK4 is a member of a family of activating endoproteinases
In this review, all members of this family of enzymes are called proprotein convertase subtilisin/kexin type # (PCSK#, where # stands for a number), according to the proposed unifying nomenclature (Fugere and Day, 2005) . Aliases found in the scientific literature are provided in Table I . Among proteases, PCSKs belong to the family of serine proteases of the subtilisin subtype. Based on structural similarities to yeast and bacterial proteases, they are further subdivided into kexin-like, pyrolysin-like or proteinase K-like clans (Table I) (Siezen and Leunissen, 1997; Seidah and Chretien, 1999; Seidah and Prat, 2002) .
PCSKs are encoded by genes of different exon numbers and introns sizes. Except for PCSK3 and PCSK6, these genes map on different chromosomes. They are transcribed in all nucleated cells in different combinations and amounts. Based on the relative mRNA abundance, this transcription is considered ubiquitous, widespread or restricted Seidah and Prat, 2002) . However, global transcriptome analysis using DNA microarrays and sequencing of cloned expressed sequence tags (ESTs) have shown that expression of all PCSK genes spreads across tissues and cell types. Often, the transcription produces one major mRNA form and several minor ones resulting from the use of alternative sites of transcription start (Ayoubi et al., 1994) , splicing Tsuji et al., 1997) or polyadenylation (Ftouhi et al., 1994) .
PCSKs are biosynthesized in the endoplasmic reticulum (ER) as multidomain preproproteins consisting of an N-terminal signal peptide followed by a pro domain, a conserved catalytic domain, a P domain, and a variable C-terminal domain (Fig. 1) . After cotranslational removal of the signal peptide, the resulting proPCSK undergoes maturation by autocatalytic cleavage between the pro and the catalytic domains, within a cleavage motif that is also recognized by the fully activated enzyme in the primary sequence of its physiological substrates (Muller and Lindberg, 1999; Seidah and Chretien, 1999; Seidah and Prat, 2002; Seidah et al., 2008) . As demonstrated experimentally for PCSK3 (Anderson et al., 1997 (Anderson et al., , 2002 , it is generally believed that the propeptide remains attached to the mature enzyme until the complex reaches the trans-Golgi network (TGN), where a secondary autocatalytic cleavage within the propeptide dissociates the complex, rendering the enzyme fully active (see Fig. 1 ). Other post-translational modifications known to occur include glycosylation Creemers et al., 1996; van de Loo et al., 1997) , phosphorylation (Jones et al., 1995; Dewpura et al., 2008) , palmitoylation (van de Loo et al., 2000) , sulfation (Benjannet et al., , 2006 and C-terminal truncation (Vindrola and Lindberg, 1992) . The final destination of the activated PCSK is variable: the enzyme could be retained in the Golgi or the TGN, stored in neuroendocrine secretory granules, anchored to or associated with the plasma membrane, recycled into endosomes, or secreted or shed into the extracellular milieu (Seidah and Prat, 2002; Seidah et al., 2006; Mayer et al., 2008) .
The enzymatic activities of PCSKs are variably dependent on calcium levels and pH in the successive compartments of the secretory pathway. The cleavage specificity of the three PCSK clans is shown in Table I . Most physiological products of precursor processing by kexinlike PCSKs are implicated in cell signaling as ligands or receptors. These include hormones, neuropeptides and growth factors as well as cell surface receptors and integrins (Nakayama, 1997; Seidah and Chretien, 1999 
a Furin, fes upstream protein; LPC, lymphoma proprotein convertase; NARC-1, neural apoptosis-regulated convertase 1; PACE, paired basic amino acid cleaving enzyme; PC, proprotein convertase; S1P, site-one protease; SKI-1, subtilisin/kexin isozyme 1; SPC, subtilisin-like proprotein convertase. b X stands for any amino acid except Cys, '/' for 'or', '#' for cleavage and 'n' for position P2, P4, P6 or P8. After cleavage, the C-terminally exposed basic residue is removed by a carboxypeptidase (CP) unless preceded by a Pro. A Gly exposed by CP can be converted to an amide group by peptidylglycine-alpha amidating monooxygenase (PAM). c Z stands for any amino acid except Pro, Cys, Glu and Val (Espenshade et al., 1999; Toure et al., 2000) . d This is the site of autocatalytic cleavage of proPCSK9 after its prodomain V-F-A-Q#S-I-P (Seidah et al., 2003; Benjannet et al., 2004; Grozdanov et al., 2006) . Mature PCSK9 has no known physiological substrate.
transcriptional activators of genes involved in lipid biosynthetic pathways (Horton et al., 2002) ; PCSK9 promotes the degradation of the receptor for low density lipoprotein (LDL) in hepatocytes, reducing plasma LDL uptake by these cells (Horton et al., 2007; Lopez, 2008) . For most PCSKs, genetic nullizygosity causes biological anomalies ranging from embryonic lethality and developmental defects to metabolic disturbances and infertility (Taylor et al., 2003; Scamuffa et al., 2006; Creemers and Khatib, 2008; Essalmani et al., 2008) . Molecular analysis of precursor processing in PCSK-null mice has revealed both substrate specificity and redundancy among the convertases (Creemers and Khatib, 2008) .
Biochemical properties of PCSK4
Structure and expression PCSK4 is the product of a 9 kb, 15 exon gene located on human chromosome 19 (symbol: PCSK4) and mouse chromosome 10 (symbol: Pcsk4) (Mbikay et al., 1995) . Organizationally and sequence wise, the PCSK4 gene is more homologous to PCSK3 gene than to any other gene of the PCSK family (Mbikay et al., 1995) . Global profiling of mouse and human transcriptome using DNA microarrays (published online at http://symatlas.gnf.org/) reveals that PCSK4 transcripts are most abundant in reproductive organs, particularly in the testis. In this organ, they are primarily found in germ cells, mostly in spermatocytes and round spermatids (Nakayama et al., 1992; Seidah et al., 1992; Torii et al., 1993; Bergeron et al., 2000; Gyamera-Acheampong et al., 2006) . In female mice, the transcripts are detected by reverse transcriptase -polymerase chain reaction (RT -PCR) in mouse ovarian macrophage-like cells (Tadros et al., 2001) as well as in unfertilized and fertilized oocytes (St. Germain et al., 2005) . Their presence has also been demonstrated in human placenta and placental cell lines (Qiu et al., 2005) as well as in human endometrium (Freyer et al., 2007) . In adult frog, testis and ovary are the primary sites of expression of these transcripts, followed by brain, oocytes and early embryos (Nelsen et al., 2005) .
Immunoreactive PCSK4 protein is present in mouse male germ cells and on the surface of epididymal sperm (Gyamera-Acheampong et al., 2006), as well as in human placenta (Qiu et al., 2005) . Overall, this distribution strongly suggests that the function of PCSK4 is linked to reproductive processes, including fertilization and early development.
Besides the fact that during spermatogenesis PCSK4 transcripts first appear at the pachetene spermatocyte stage and later disappear at the elongated spermatid stage, nothing is known about the regulation of PCSK4 gene transcription. Alignment of the 2 kb sequence upstream of the transcription start site of the human and mouse gene reveals a 600 bp internal domain of high sequence similarity containing several conserved binding sites for transcription factors (Supplementary data, Fig. S1 ). This cluster of regulatory elements is also found in the upstream region of rat and macaque PCSK4 genes. The expression level and pattern of this gene may be determined by interactions of multiple factors over this domain. One of these factors, the nuclear deformed epidermal autoregulatory factor-1 (DEAF-1) related factor (NURD) is reportedly expressed at high levels in male germ cells (Huggenvik et al., 1998) .
In rodents, the PCSK4 gene is transcribed into a major mRNA of 3 kb and several shorter isoforms resulting from alternate splicing, which in mouse testis represent 10% of all Pcsk4 transcripts (Seidah et al., 1992; Mbikay et al., 1994) . The open reading frame (ORF) of these alternate mRNAs encode proteins with various deletions or insertions when compared with the major isoform (Seidah et al., 1992; Mbikay et al., 1994) . The physiological significance of these isoforms is unclear. Production of alternative mRNA isoforms has been interpreted to be a mechanism of extending the informational content of the genome and expanding the proteome (Maniatis and Tasic, 2002) . It may also play a regulatory role when it introduces a premature nonsense codon in the ORF, effectively reducing the level of translatable mRNA by making the transcripts susceptible to nonsense-mediated decay (Lewis et al., 2003) . An alignment of the PCSK4 protein sequence of humans, rodents and frogs reveals a remarkable conservation of its sequence, which extends from the prodomain to the P domain (Fig. 2 ). This high The signal peptide (sp) directs the nascent precursor toward the secretory pathway. The prodomain (PRO) serves as intramolecular chaperone and transient inhibitor. The catalytic domain (CAT) carries the Asp-His -Ser catalytic triad characteristic of serine proteinase. The P(rotease) domain influences Ca 2þ and pH dependence; it also shows a beta sandwich fold typical of galactose binding domain-like which may mediate attachment to carbohydrates, phospholipids or membrane receptors. The variable C-terminal (CT) domain influences intracellular localization, in -out recycling as well as protein -protein interactions; it also carries a transmembrane (TM) domain. Putative N-glycosylation sites are indicated by buds. Underneath the prodomain and its junction to the CAT domain are given the sequence around the primary and secondary basic cleavage sites in proPCSK4 (capital characters) and proPCSK3 (small characters). Note the absence of a basic secondary cleavage site in the prodomain of PCSK4.
conservation is in contrast with many mammalian sperm-specific proteins, which appear to have rapidly evolved during speciation (Torgerson et al., 2002) . It suggests that PCSK4 gene was positively selected during evolution because of its biological importance. The C-terminal domain is the least conserved. In primates, besides being longer and richer in Cys residues, this domain also carries a transmembrane domain, making PCSK4 a type-1 membrane protein.
PCSK4 from mouse testis and sperm migrates on western blots with an electrophoretic mobility of 54 kDa (Mbikay et al., 1997; Tadros et al., 2001; Gyamera-Acheampong et al., 2006) . This molecular mass is smaller than predicted for mature mouse PCSK4 (62 kDa), an indication that the latter may be subject to further proteolytic processing, most likely to C-terminal truncation. The biosynthesis and trafficking of PCSK4 in the secretory pathway has not been elucidated. When transduced into somatic cells in culture, most of it is retained in the ER as proPCSK4 (our unpublished data). It is possible that, like proPCSK2 (Muller et al., 1997; Mbikay et al., 2001) , this zymogen requires the assistance of a specific chaperone to efficiently navigate through the secretory pathway. Furthermore, it is still unclear how mature PCSK4 becomes fully activated since its prodomain lacks a recognizable internal secondary site (see Fig. 1 ). In most PCSKs, cleavage at this site rids the mature enzyme of the inhibitory propeptide generated by the primary cleavage at the demarcation between the pro and the catalytic domains (Anderson et al., 1997 (Anderson et al., , 2002 . Rodent PCSK4 lacks a transmembrane domain in its C-terminal domain. Yet, it is detectable by immunoelectron microscopy at the surface of intact mouse sperm (Gyamera-Acheampong et al., 2006) . The nature of this association remains to be elucidated.
PCSK4 enzymatic activity
Despite the inefficient maturation and trafficking of proPCSK4 in transfected cells, it has been possible to detect its activity in the culture media of these cells (Basak et al., 1999 (Basak et al., , 2004 and, more recently, to partially purify the enzyme from these media (Basak et al., 2008) . Like all kexin-like PCSKs, recombinant PCSK4 was shown in vitro to cleave synthetic peptide substrates after an Arg in a basic sequence context; most often after paired basic residues (KR#, RR#) (Remacle et al., 2008) , but it cleaves uniquely better after a single Arg preceded by a Lys at P4 (KXXR#, X ¼ any residue) (Basak et al., 1999 (Basak et al., , 2004 (Basak et al., , 2008 . Its optimal activity is observed near Figure 2 Alignment of tetrapod PCSK4.
NCBI database (http://www.ncbi.nlm.nih.gov/) accession numbers for humans (Homo sapiens), rat (Rattus norvegicus), mouse (Mus musculus) and frog (Xenopus laevis) preproPCSK4 sequences are Q6UW60, EDL89 295, NP_032819 and AAW83 023, respectively. The sequences were aligned using the MULTALIN online algorithm (http://pbil.ibcp.fr/). Residues that are conserved in all four species are written in red; those conserved in two or three, in blue. Cleavage sites leading to removal of the signal peptide and the prodomain are indicated with a filled and an open arrow, respectively. The catalytic domain is delimited with blue brackets. The active residues in the catalytic domain are indicated with dots. The Arg-Gly-Asp (RGD) motif that interacts with integrin is boxed. The transmembrane membranes are underlined.
neutral pH and at about 2 mM Ca 2þ (Basak et al., 1999) . Ex vivo, PCSK4 was also shown to process a recombinant 156 amino acid long human proinsulin-like growth factor 2 (proIGF2) within the KSER 68 #DV sequence, resulting in the release of the most active IGF2 1 -67 after carboxypeptidase (CP)-mediated removal of the terminal basic residue (Qiu et al., 2005) . This site is not recognized by PCSK1, PCSK3 or PCSK7, which cleave only within the RLRR 104 #FF motif, generating a larger IGF2 1 -101 (Duguay et al., 1998) .
PCSK4 in reproduction: lessons from the PCSK4 deficient mouse
Physiological defects
The production of a PCSK4-null mouse by disruption of its genomic locus (Mbikay et al., 1997) has provided significant insights into the biological functions of this enzyme. The fertility phenotype of this mouse is summarized in Table II .
Male phenotype
The original null mice were of mixed 129Sv/C57BL/6J (B6) genetic background. Null male mice were severely subfertile (25% productive mating; 0.8 pup/litter, n ¼ 24) (Mbikay et al., 1997) . No difference between wild-type and null mice was observed in seminiferous epithelium morphology and sperm number or motility. However, hyperactivation of PCSK4-null sperm after capacitation was half that of wild type cells. In vitro fertilization (IVF) of normal oocytes with mutant sperm resulted in less embryos developing to the blastocyst stage (Mbikay et al., 1997) . When the mutation was backcrossed into the B6 genetic background, null male congenics were infertile and their sperms were unable to fertilize oocytes in vitro (GyameraAcheampong et al., 2006). PCSK4-null sperm are capacitated faster and undergo near complete acrosome reaction in the presence of amounts of zona pellucida that are ineffective on normal sperm; they also bind less efficiently to intact oocytes (Gyamera-Acheampong et al., 2006).
Female phenotype
Female mice were found to be mildly subfertile, exhibiting a 23% reduction in productive mating and 65% reduction in litter size relative to heterozygous littermates (Mbikay et al., 1997) . This subfertility appears to be caused in part by impaired folliculogenesis (Tadros et al., 2001) .
Search for potential substrates
The availability of the PCSK4-null mouse has also provided the opportunity search for physiological substrates of this enzyme in gonads. This search has been guided by the following criteria: (i) the substrate must be a secretory precursor protein activated by limited proteolysis at sites recognizable by PCSK4; (ii) the precursor must be expressed in the same cells as PCSK4; (iii) its proteolytic processing must be impaired in PCSK4-null mice and (iv) its deficiency must cause an infertility phenotype.
In testis
Male germ cells biosynthesize several precursor proteins that are known to need PCSK-mediated limited endoproteolysis to become active. Counted among these proteins are the following: proenkephalin (Kew et al., 1990; Breslin et al., 1993) , pronerve growth factor (Parvinen et al., 1992; Seidah et al., 1996) , propituitary adenylate cyclase-activating peptide (proPACAP), (Shioda et al., 1994; Li et al., 1998 Li et al., , 1999 , insulin-like growth factor-1 (IGF-1) Reduced levels of spermatid PACAP-regulated MAPKs (Li et al., 2004) Lack of testicular PACAP peptides (Li et al., 2000a, b) Female mice Lack of ovarian PACAP peptides (Li et al., 2000a, b) PCSK4 protease and fertility (Lehmann et al., 1998; Naz and Padman, 1999) , hepatocyte growth factor receptor (Komada et al., 1993; Depuydt et al., 1996) and members of the a-disintegrin-and-metalloproteinase (ADAM) family of proteins (Wolfsberg and White, 1996; Blobel, 2000) . The activating endoproteolysis could be mediated not only by PCSK4, but also by PCSK7 which is also highly expressed in these cells (Bergeron et al., 2000) . Therefore, if impaired proteolytic activation of specific precursor proteins is the main cause of infertility in male PCSK4-null mice, this activation must depend exclusively on this convertase.
ProPACAP
To date, the only substrate unambiguously identified as a PCSK4 substrate in male germ cells is proPACAP. Its active products, PACAP38 and PACAP27, are undetectable in PCSK4-null mouse testis (Li et al., 2000a, b) . Like PCSK4, PACAP peptides are produced during spermiogenesis (Shioda et al., 1994) . Their receptors are found in Leydig cells and spermatids. PACAPs induce increased production of cAMP, an early second messenger in the cascade of signaling events that lead to changes in gene expression or cellular metabolism (Vaudry et al., 2000) . Ex vivo, they have been shown to stimulate steroidogenesis in Leydig cells (El-Gehani et al., 2000) and protein synthesis in spermatocytes (West et al., 1995) . In the PCSK4-null mouse, altered signaling is suggested by the reduction of PACAP-regulated mitogen activated protein kinase (MAPK) expression in spermatids (Li et al., 2004) . MAPKs have been implicated in sperm capacitation and acrosome reaction, but their mechanism of action is unclear (Almog and Naor, 2008) . More investigation is needed to determine whether and how the reduction of PACAP-regulated MAPKs causes the fertilization defects observed in PCSK4-null mice. PACAP-null mice show a complex phenotype, which includes disturbances of thermogenesis, lipid and carbohydrate metabolism as well as neuronal development (Gray et al., 2001; Sherwood et al., 2007) . Surviving male mutant mice are fertile. At 4 months of age, steroidogenesis in the testes of mutant mice is lower than in those of wild-type counterparts, but spermatogenesis appears normal. By 15 months of age, steroidogenesis remains unchanged in PACAP-null mice, whereas, in wild-type counterparts, it decreases to the level detected in the mutant mouse. Moreover, the seminiferous epithelium of old mutant mice remains largely devoid of signs of degeneration observable in same age wild-type mice (Lacombe et al., 2006) . Collectively, these observations indicate that PACAP deficiency delays of testicular deterioration associated with aging. The fertility of PACAP-null male mice implies that lack of PACAP peptides in male germ cells and sperm is probably not the primary cause of infertility in PCSK4-null mice. It remains to be verified whether this lack protects these mice against age-induced testicular degeneration. Interestingly, PCSK4 deficiency is associated with a 20-fold increase in testicular proPACAP mRNA (Li et al., 2000a, b) , suggesting that lack of PACAP peptides causes a feedback stimulation of transcription of its gene or stabilization of its mRNA. This feedback transcriptional up-regulation of substrate gene expression has also been observed for hypothalamic growth hormone-releasing hormone in the PCSK1-null mouse (Zhu et al., 2002) and pancreatic islet proglucagon in the PCSK2 deficient mouse (Furuta et al., 2001) . It probably reflects an obligatory and exclusive enzymatic link between a PCSK and its most physiologically important substrates.
ADAMs:
Members of the ADAM family, in particular ADAM1 (fertilin a), ADAM2 (fertilin b) and ADAM3 (cyritestin), are potential substrates for PCSK4. These ADAMs are biosynthesized in male germ cells as type-1 transmembrane precursor proteins and undergo a cascade of testicular and post-testicular proteolytic cleavages to their acrosomebound forms (Linder et al., 1995; Lum and Blobel, 1997; Blobel, 2000) . Their primary sequences carry several potential cleavage sites for PCSK4. Furthermore, synthetic peptides encompassing some of these sites have been shown to be susceptible to PCSK4-catalyzed hydrolysis in vitro (Basak et al., 1999 (Basak et al., , 2004 (Basak et al., , 2008 . Of particular interest are sites located closely upstream of the CRXXXXCDXXEXC disintegrin motif, known to interact with integrins. Synthetic peptides containing this motif can block sperm -oocyte fusion in IVF assays (Yuan et al., 1997; Evans et al., 1998; Bigler et al., 2000; Takahashi et al., 2001) . One could speculate that PCSK-mediated cleavage at these upstream sites in vivo might expose the disintegrin domain and contribute to its functionality. In mouse, inactivation of ADAM2 and ADAM3 genes causes a male infertility phenotype (Cho et al., 1998 (Cho et al., , 2000 Shamsadin et al., 1999; Nishimura et al., 2001) . Like in PCSK4-null mice, this phenotype includes reduced sperm ability to bind to zona pellucida. However, sperm -oocyte membrane fusion is normal, indicating that neither ADAM plays a unique role in this process. Interestingly, ADAM2 or ADAM3 deficiency is accompanied by changes in the expression of other sperm proteins including ADAM1 (Nishimura et al., 2001 (Nishimura et al., , 2004 . Aberrant redistribution or loss of sperm surface proteins has also been observed following disruption of the gene for testicular chaperone calmegin (Ikawa et al., 1997) or angiotensin converting enzyme (Yamaguchi et al., 2006) . These observations suggest that a strict stoichiometry of interacting proteins may be necessary for the fertilization competence of sperm cells. There is currently no evidence that lack of PCSK4 leads to impaired processing of testicular ADAMs.
In ovary ProPACAP:
The ovaries of PCSK4-null female mice are also devoid of PACAP peptides (Li et al., 2000a, b) and show signs of impaired folliculogenesis (Tadros et al., 2001) . In contrast, PACAP-null female mice show normal ovarian morphology and ovulation, but the mating success is only one-fifth of wild-type controls due to an implantation defect (Isaac and Sherwood, 2008) . The possibility of an implantation defect in PCSK4-null mice has not been explored. Like in testis, PCSK4 deficiency is associated with a significant increase in proPACAP mRNA (Li et al., 2000a, b) , suggesting an enzyme-substrate obligatory link in this organ too.
ProIGFs:
It is possible that implantation and placentation defects also contribute to the subfertility of PCSK4-null female mice. PCSK4 has been shown to stimulate placental trophoblast cell migration by converting proIGF2 to its most active form (Qiu et al., 2005) . IGFs promote fetoplacental growth (Fowden, 2003) . In mouse, lack of placental IGF2 due to disruption of the placenta-specific promoter of the Igf2 gene leads to reduced placental diffusional exchange of nutrients and smaller fetuses (Sibley et al., 2004) . In rat, proIGF2 is the major form of circulating IGF2 and its conversion to smaller active forms increases during pregnancy, in fetuses and neonates (Qiu et al., 2007) , suggesting a coordinate up-regulation PCSK activities, including that of PCSK4. In humans, defects of placental IGF signaling have been associated with intrauterine growth restriction (IUGR) (Laviola et al., 2005) and IUGR has been associated with higher circulating levels of unprocessed proIGF2 (Qiu et al., 2005) . The blood levels of this precursor in wildtype and PCSK4-null mice have not been compared. If higher levels are observed in the mutant mice, this would further support the suggestion that PCSK4 is a critical proIGF2 convertase.
Additional questions and considerations
Could PCSK4 itself be a zona pellucida ligand?
The binding of the PCSK9 to LDL at the surface of hepatocytes leading to post-endocytosis degradation of the receptor (Lopez, 2008 ) is a recent precedent for a non-enzymatic function of a member of the PCSK family. Through the galactose binding-like fold and the RGD motif located in its P domain (see Fig. 2 ), sperm PCSK4 could attach zona pellucida carbohydrates and oolemma integrins, respectively, and thus contribute to the cascade of events leading to fertilization. However, this attachment, if it occurs, might not involve cell-cell interactions since we have observed that acrosome-reacted sperm no longer carry PCSK4-specific immunoreactivity on its surface.
Could PCSK4 affect other physiological functions?
PCSK4 expression is preferentially expressed in, but is not restricted to, reproductive tissues. An initial northern blot survey showed that most neuroendocrine cell lines contain a 1.6 kb PCSK4-specific transcript , whose ORF remains to be elucidated. Moreover, a meta-analysis of numerous DNA microarray data (https://www.genevestigator.ethz.ch/) has revealed the presence of PCSK4 transcripts in several other tissues. These include liver, adrenal cortex, pituitary gland and various regions of the brain, especially the hypothalamic lateral nucleus, globus pallidus and cerebral cortex. This wider distribution suggests that PCSK4 may subtly influence non-reproductive functions as well, especially in neuronal and endocrine systems.
Clinical implications of PCSK4 for human fertility
The body of evidence discussed above strongly indicates that PCSK4 is important for male fertility in mouse. The high conservation of its sequence among tetrapods, the testicular abundance of its mRNA in mammals and its presence on human sperm plasma membrane overlying the acrosome (our unpublished data) suggest that it may be critical for human fertility too. In the western world, one in six couples experiences fertility difficulties. Half of these cases are due to the male factor infertility (MFI). One-third of MFI cases are associated with chromosomal abnormalities; the remaining two-thirds are of unknown origin (Bhasin et al., 1994; Brugh et al., 2003) . Could PCSK4 deficiency contribute to some of the idiopathic infertilities, either because of failed expression, abnormal expression or impaired activity? Could PCSK4 be a target for male contraception?
PCSK4-based assays for sperm fertilizing ability
A critical role of PCSK4 in human fertility would render unlikely intergenerational transmission of severely deleterious mutations in its gene. On the other hand, alteration in expression due to developmental or environmental injuries could be a cause of infertility in human. Such injuries could be reflected by abnormal transcription of the gene. A review of EST sequences deposited in DNA databases indicate that, like in mouse, human PCSK4 gene is transcribed in multiple mRNA isoforms resulting from exon skipping and optional exon insertion and encoding PCSK4 isoforms with inframe or frameshift insertions/ deletions. Enzymatically, these isoforms could be active, inactive or inhibitory. An assay for the overall PCSK4 activity per a given sperm number or per levels of immunoreactive PCSK4 may provide some indication of the fertilizing ability of the sperm pool. Using a PCSK4-specific fluorogenic substrate, this activity could be deduced from the total PCSK-like hydrolytic minus the remaining activity in the presence of an excess of PCSK4-specific inhibitor. 7B2, a PCSK2-specific inhibitor, has been used in a similar manner to measure the activity of this convertase in various mouse tissues . Alternatively, PCR-based profiling of Pcsk4 mRNA isoforms in ejaculated sperm could be used to assess the quality of PCSK4 gene expression. A number of reports of the last decade have shown that ejaculated human sperm contains a variety of mRNAs (Miller et al., 1999 (Miller et al., , 2005 Ostermeier et al., 2002 Ostermeier et al., , 2005a Grunewald et al., 2005; Miller and Ostermeier, 2006) . This limited transcriptome is a remnant of transcriptional events that took place during spermatogenesis (Grunewald et al., 2005) . It is transmitted to the oocyte upon fertilization and may be of importance for early development. Because ejaculated sperm can be obtained with relative ease, changes in its RNA content and profile can be used to assess fertility and the consequences of environmental toxicants on fertility (Ostermeier et al., 2002; Miller and Ostermeier, 2006) . If PCSK4 transcripts can be unambiguously detected in ejaculated human sperm, their splicing profile could possibly be used as a marker of sperm quality.
In the context of artificial reproductive technology, it may be worth examining whether supplementation of purified recombinant PCSK4 to deficient sperm could improve their oocyte fertilization ability in vitro.
PCSK4: an antisperm contraceptive target?
The absence of overt spermatogenesis or steroidogenesis defects in male PCSK4-null mice suggests that therapeutic targeting of PCSK4 for contraceptive purposes in man may not be associated with the endocrinological pitfalls of hormonal contraception. Current efforts to develop PCSK-specific inhibitors take advantage of the properties of the prodomain as an intramolecular chaperone and inhibitor Basak, 2005) . A synthetic peptide based on the sequence overlapping the demarcation between the pro and the catalytic domains of PCSK4 has recently been shown to inhibit this enzyme at low micromolar concentrations (Basak et al., 2008) . However, prodomain-based inhibitors often exhibit broad specificity for members of the PCSK family . Restricting this specificity remains a major challenge. Additional challenges include the mode of administration of the inhibitor and its immunogenicity. Topical application in the female reproductive track is a conceivable PCSK4 protease and fertility approach. Mucosal or humoral antibodies induced by this application may eventually counter the contraceptive effect of the inhibitor. These challenges could eventually be surmounted. Success in this effort will depend on a better understanding of the biological functions of PCSK4 and its natural substrates.
Conclusion
Limited endoproteolysis of precursor proteins is a mechanism evolved by all cells to regulate the production and diversity of bioactive proteins. PCSKs are major mediators of this processing in the secretory pathway of eukaryotic cells. The preferential expression of PCSK4 in vertebrate male gonads implies that this enzyme is particularly adapted to mediate the activation of secretory proteins of relevance for male fertility. Currently, these proteins are largely unknown. With the availability of a mouse model of genetic PCSK4 deficiency, comparative proteomics and peptidomics of wild-type and mutant germ cells and spermatozoa could be conducted to search for these substrates. The enzymatic link could be validated by cotransduction of the putative substrate and the enzyme in an appropriate cell line. Identification of these substrates is a necessary step toward elucidating the cascade of cellular events initiated by PCSK4 cleavages and leading to sperm acquisition of fertilization competence. The role of PCSK4 in folliculogenesis, embryo development and implantation as well as fetal growth remains to be defined. The enzyme may influence these events through its unique ability to process proIGFs to their most active forms. Since there is a cornucopia of global gene expression data in health and disease online, appropriate bioinformatic algorithms could be used to explore other biological pathways, where PCSK4, this primarily gonadal protease, may play more subtle physiological roles.
